Physician profile
Nikia Fishback
NPI 1487235412
$1,957.90
in general payments reported to CMS, 2019-2025
20 companies · $541 in 2025
The $541 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $287 · 2023: $585 · 2024: $545 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $410.90 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $303.53 | 2022-2025 | |
| Hologic Sales and Service, LLC | $183.99 | 2022-2024 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $160.64 | 2022-2025 | |
| Sage Therapeutics, LLC | $128.79 | 2023-2025 | Zurzuvae |
| Exeltis, USA INC. | $126.89 | 2022-2025 | Slynd |
| Pfizer INC. | $107.94 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $102.47 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $78.66 | 2023 | Ova1 |
| Organon LLC | $74.18 | 2024-2025 | Nexplanon |
| Myovant Sciences INC. | $58.74 | 2022 | |
| Davol INC. | $46.85 | 2023-2025 | Arista Ah Flexitip, Arista |
| Astellas Pharma US INC | $40.97 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $33.24 | 2023 | |
| Bard Peripheral Vascular, INC. | $20.34 | 2024 | Arista Ah Flexitip |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $18.51 | 2022 | |
| Lilly USA, LLC | $17.20 | 2025 | Zepbound |
| Therapeuticsmd, INC. | $15.77 | 2022 | |
| Exact Sciences Corporation | $14.92 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $13.37 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikia Fishback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.